FDA Inspection 942254 — Central California Blood Center

Central California Blood Center — FEI 3007794996

The FDA completed an inspection of Central California Blood Center on Sep 16, 2015 in Fresno, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Sep 16, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fresno, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.